Showing 1 - 9 results of 9 for search 'KARIN JÖHRER', query time: 0.04s Refine Results
  1. 1
    Multiple Myeloma Inhibitory Activity of Plant Natural Products

    Multiple Myeloma Inhibitory Activity of Plant Natural Products by Karin Jöhrer, Serhat Sezai Ҫiҫek

    Published 2021-05-01
    Get full text
    Article
  2. 2
    Structure-Guided Identification of Black Cohosh (<i>Actaea racemosa</i>) Triterpenoids with In Vitro Activity against Multiple Myeloma

    Structure-Guided Identification of Black Cohosh (<i>Actaea racemosa</i>) Triterpenoids with In Vitro Activity against Multiple Myeloma by Karin Jöhrer, Hermann Stuppner, Richard Greil, Serhat Sezai Çiçek

    Published 2020-02-01
    Get full text
    Article
  3. 3
    Flavones, Flavonols, Lignans, and Caffeic Acid Derivatives from <i>Dracocephalum moldavica</i> and Their In Vitro Effects on Multiple Myeloma and Acute Myeloid Leukemia

    Flavones, Flavonols, Lignans, and Caffeic Acid Derivatives from <i>Dracocephalum moldavica</i> and Their In Vitro Effects on Multiple Myeloma and Acute Myeloid Leukemia by Karin Jöhrer, Mayra Galarza Pérez, Brigitte Kircher, Serhat Sezai Çiçek

    Published 2022-11-01
    Get full text
    Article
  4. 4
    Cytotoxic Properties of Damiana (<i>Turnera diffusa</i>) Extracts and Constituents and A Validated Quantitative UHPLC-DAD Assay

    Cytotoxic Properties of Damiana (<i>Turnera diffusa</i>) Extracts and Constituents and A Validated Quantitative UHPLC-DAD Assay by Johanna Willer, Karin Jöhrer, Richard Greil, Christian Zidorn, Serhat Sezai Çiçek

    Published 2019-02-01
    Get full text
    Article
  5. 5
    A new trisaccharide derivative from Prenanthes purpurea - SHORT COMMUNICATION

    A new trisaccharide derivative from Prenanthes purpurea - SHORT COMMUNICATION by MICHAELA POSCH, KARIN JÖHRER, SERHAT SEZAI CICEK, RICHARD GREIL, ERNST P. ELLMERER, CHRISTIAN ZIDORN

    Published 2011-06-01
    Get full text
    Article
  6. 6
    High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.

    High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma. by Normann Steiner, Roman Hajek, Sabina Sevcikova, Bojana Borjan, Karin Jöhrer, Georg Göbel, Gerold Untergasser, Eberhard Gunsilius

    Published 2017-01-01
    Get full text
    Article
  7. 7
    The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets.

    The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets. by Normann Steiner, Udo Müller, Roman Hajek, Sabina Sevcikova, Bojana Borjan, Karin Jöhrer, Georg Göbel, Andreas Pircher, Eberhard Gunsilius

    Published 2018-01-01
    Get full text
    Article
  8. 8
    The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis

    The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis by Normann Steiner, Karin Jöhrer, Selina Plewan, Andrea Brunner-Véber, Georg Göbel, David Nachbaur, Dominik Wolf, Eberhard Gunsilius, Gerold Untergasser

    Published 2020-08-01
    Get full text
    Article
  9. 9
    Cytotoxic Compounds of Two Demosponges (<i>Aplysina aerophoba</i> and <i>Spongia</i> sp.) from the Aegean Sea

    Cytotoxic Compounds of Two Demosponges (<i>Aplysina aerophoba</i> and <i>Spongia</i> sp.) from the Aegean Sea by Maria Orfanoudaki, Anja Hartmann, Mostafa Alilou, Naida Mehic, Marcel Kwiatkowski, Karin Jöhrer, Hieu Nguyen Ngoc, Andreas Hensel, Richard Greil, Markus Ganzera

    Published 2021-05-01
    Get full text
    Article

Search Tools: